Displaying all 2 publications

Abstract:
Sort:
  1. Attainment of goal and normalized lipid levels with lipid-modifying therapy in Malaysia
    Hsu TY, Chirovsky D, Moy FM, Ambegaonkar BM
    Clin Ther, 2013 Apr;35(4):450-60.
    PMID: 23481458 DOI: 10.1016/j.clinthera.2013.02.004
    Although LDL-C is the primary lipid target for coronary heart disease (CHD) risk reduction, HDL-C and triglycerides (TG) have also emerged as CHD risk factors.
  2. Prevalence of lipid abnormalities and attainment of normal lipid levels among patients with dyslipidaemia: a pooled analysis of observational studies from five Asian countries
    Unniachan S, Bash LD, Khovidhunkit W, Sri RZ, Vicaldo E, Recto C, et al.
    Int J Clin Pract, 2014 Aug;68(8):1010-9.
    PMID: 24666791 DOI: 10.1111/ijcp.12407
    Guidelines emphasise the importance of low-density lipoprotein cholesterol (LDL-C) goals for cardiovascular risk reduction. Given the importance of association between high-density lipoprotein (HDL-C) and triglycerides (TG) normal levels and cardiovascular risk, there is an additional need to further evaluate diverse dyslipidaemic populations.
Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator ([email protected])

External Links